Women Health Therapeutics Market Size 2024-2028
The women health therapeutics market size is forecast to increase by USD 37.2 billion, at a CAGR of 6% between 2023 and 2028.
- The market is experiencing significant growth due to the increasing focus on women's health and wellbeing. The rising awareness of various gynecological diseases, including infertility, menstrual disorders, and sexually transmitted infections, is driving market expansion. However, challenges persist in the effective diagnosis and treatment of these conditions, which may hinder market progress. Despite these obstacles, opportunities exist for companies to innovate and develop advanced therapeutic solutions to address the unmet needs of women's health. Strategic partnerships, research collaborations, and regulatory approvals can help companies navigate these challenges and capitalize on the market's potential.
- By staying informed of the latest trends and addressing the unique needs of women's health, market participants can position themselves for success in this dynamic and growing industry.
What will be the Size of the Women Health Therapeutics Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The women's health therapeutics market continues to evolve, driven by the ongoing research and development of innovative solutions for various health concerns. Bone density, a critical aspect of women's health, is being addressed through both prescription medications and over-the-counter supplements, including calcium and vitamin D. The role of natural remedies, such as black cohosh and red clover, in bone health management is also gaining attention. Cardiovascular health is another significant area of focus, with lifestyle modifications, such as diet and exercise, and pharmaceutical drugs playing essential roles. Sexual dysfunction, a common concern for women, is being addressed through a range of treatments, from prescription medications to herbal remedies and digital health solutions.
Drug development is ongoing for conditions like osteoporosis, with a focus on improving treatment adherence and minimizing adverse effects. The role of nutritional therapy, including soy isoflavones and vitamin D supplements, in osteoporosis prevention and treatment is also being explored. Stress management, a crucial component of overall health, is being addressed through various means, including mobile applications, lifestyle modifications, and personalized medicine. The integration of data analytics and predictive modeling in healthcare is enabling more effective patient education and improving healthcare costs. Women's health therapeutics also encompasses the management of menopause symptoms, such as hot flashes, night sweats, mood swings, and sleep disturbances.
Healthcare professionals are working to improve patient satisfaction through better communication and the use of clinical trials to evaluate the long-term effects of various treatments. Insurance coverage and regulatory approvals continue to shape the market, with ongoing discussions surrounding the role of herbal remedies and dietary supplements in women's health. The integration of technology, such as digital health solutions and exercise programs, is also transforming the way women manage their health and improve their quality of life.
How is this Women Health Therapeutics Industry segmented?
The women health therapeutics industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Fertility
- Oncology
- Menopause
- Infection
- Others
- Distribution Channel
- HospitalPharmacy
- RetailPharmacy
- OnlinePharmacy
- HospitalPharmacy
- RetailPharmacy
- OnlinePharmacy
- Therapeutics Drug
- ACTONEL
- YAZ
- Yasmin
- Yasminelle
- FORTEO
- Minastrin24Fe
- Mirena
- NuvaRing
- ORTHOTRICYLO
- Premarin
- Prolia
- Reclast/Aclasta
- ACTONEL
- YAZ
- Yasmin
- Yasminelle
- FORTEO
- Minastrin24Fe
- Mirena
- NuvaRing
- ORTHOTRICYLO
- Premarin
- Prolia
- Reclast/Aclasta
- Age Group
- 50 Year Above
- Others
- 50 Year Above
- Others
- Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- APAC
- China
- Japan
- South Korea
- South America
- Brazil
- Rest of World (ROW)
- North America
By Type Insights
The fertility segment is estimated to witness significant growth during the forecast period.
The Women's Health Therapeutics market in the US is experiencing significant growth due to various factors. According to the Centers for Disease Control and Prevention (CDC), approximately 12% of married women aged 15-44 years in the US experience infertility, leading to a high adoption of female infertility drugs. The US Department of Health and Human Services reports that 12-13 out of every 100 couples face infertility issues. In Canada, the Public Health Agency reports that one in six couples and four in ten women face fertility problems annually. The market is driven by an increase in infertility risk factors, including sexually transmitted diseases (STDs), endometriosis, polycystic ovary syndrome (PCOS), poor diet, age, and diabetes.
Infertility drugs, such as prescription medications, are widely used to address these issues. However, there is a growing trend towards alternative therapies, including nutritional therapy, herbal remedies, and lifestyle modifications. Digital health technologies, such as mobile applications and data analytics, are also gaining popularity in the market. These technologies enable personalized medicine, treatment adherence, and patient education, leading to improved patient satisfaction and healthcare costs. Regulatory approvals for bioidentical hormones and over-the-counter medications have further boosted market growth. However, there are concerns regarding the long-term effects of some pharmaceutical drugs and herbal remedies, such as adverse effects on bone density, cardiovascular health, and mood swings.
Additionally, insurance coverage and affordability remain significant challenges for patients. Clinical trials are ongoing to explore the effectiveness and safety of various treatments, including drug development for osteoporosis prevention and treatment adherence strategies. Exercise programs, stress management, and vitamin D supplements are also gaining attention for their role in improving overall health and quality of life. Predictive modeling and patient education are essential components of menopause management, which is another significant area of focus in the market. Healthcare professionals are working to address the various symptoms of menopause, including hot flashes, night sweats, vaginal atrophy, and sexual dysfunction, through a combination of pharmaceutical drugs, herbal remedies, and lifestyle modifications.
In conclusion, the Women's Health Therapeutics market in the US is experiencing significant growth due to an increase in infertility risk factors and the adoption of various treatments, including prescription medications, digital health technologies, and alternative therapies. However, challenges such as long-term effects, insurance coverage, and affordability remain significant barriers to access and adoption. Ongoing clinical trials and research are providing valuable insights into the effectiveness and safety of various treatments, enabling healthcare professionals to develop more effective and personalized approaches to women's health.
The Fertility segment was valued at USD 26.20 billion in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 48% to the growth of the global market during the forecast period.Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The women's health therapeutics market in North America is experiencing notable growth due to the rising adoption of advanced therapeutics for treating various conditions. For instance, the development of anticancer drugs is gaining traction, offering alternatives to traditional treatments like surgery for diseases such as fallopian tube cancer. Historically, chemotherapy has been the primary treatment option for this condition, often used in conjunction with surgery and radiation therapy. However, its limited efficacy and significant side effects have left a substantial gap in the market. Moreover, digital health solutions are increasingly being integrated into women's healthcare, improving patient satisfaction and access to care.
Regulatory approvals for prescription medications, such as bioidentical hormones and selective estrogen receptor modulators (SERMs), are driving market expansion. These therapies address issues like vaginal atrophy, hot flashes, and osteoporosis prevention. Nutritional therapy, including dietary supplements like vitamin D and calcium, as well as herbal remedies like black cohosh and red clover, are also gaining popularity. Lifestyle modifications, stress management, and exercise programs contribute to the market's growth. Patient education and healthcare costs are key factors influencing treatment decisions. Drug development is ongoing for various conditions, including breast and ovarian cancer risks, menopause management, and sexual dysfunction. Over-the-counter medications and personalized medicine are further expanding the market.
Data analytics and predictive modeling facilitate better patient care and treatment adherence. Pharmaceutical drugs and herbal remedies are used to address conditions like urinary tract health and mood swings. Long-term effects, such as cardiovascular health and cognitive function, are increasingly being considered. Sleep disturbances, night sweats, and insurance coverage are other factors influencing market trends. In summary, the women's health therapeutics market in North America is witnessing significant growth due to the development of novel therapeutics, increasing adoption of digital health solutions, and growing awareness of the importance of preventive measures and personalized care.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Women Health Therapeutics Industry?
- The growing focus on women's health is the primary catalyst driving market expansion in this sector.
- The global women's health therapeutics market is experiencing notable growth due to the increasing focus on women's health issues worldwide. However, there have been challenges in addressing gynecologic cancer indications, such as fallopian tube cancer and ovarian cancer, which lack sufficient awareness. To combat these challenges, numerous organizations and governments are working on raising awareness and education about these indications. For instance, the Office on Women's Health, a division of the US Department of Health and Human Services, is dedicated to critical women's health issues.
- They are implementing programs to educate the public about the severity and importance of early diagnosis and treatment for fallopian tube cancer. This heightened focus on women's health and awareness of gynecologic cancer indications is expected to significantly drive market growth.
What are the market trends shaping the Women Health Therapeutics Industry?
- The increasing recognition of the importance of gynecological health is shaping the current market trend. This heightened awareness of various gynecological diseases and the need for early detection and prevention is driving demand for innovative solutions and advancements in this field.
- Gynecological health is a significant concern for women worldwide, with various conditions such as hot flashes, vaginal atrophy, breast and endometrial cancer, and maternity disorders affecting millions. Prescription medications, digital health solutions, nutritional therapy, and bioidentical hormones are popular treatment options. According to recent research, patient satisfaction is a crucial factor influencing the selection of treatment methods. Regulatory approvals play a pivotal role in bringing innovative therapies to market. For instance, the FDA has approved several new drugs for the treatment of hot flashes and vaginal atrophy. However, adverse effects and risks, including breast and endometrial cancer, are important considerations.
- Primary care physicians often serve as the first point of contact for women seeking treatment for gynecological conditions. As awareness about these conditions grows, organizations are increasingly focusing on patient education and advocacy. For example, the Centers for Disease Control and Prevention (CDC) conducts campaigns to provide the public with accurate information about gynecological cancers. The importance of early detection and prevention cannot be overstated, making ongoing research and innovation essential.
What challenges does the Women Health Therapeutics Industry face during its growth?
- The complexities in diagnosing and treating diseases pose a significant challenge to the growth of the healthcare industry.
- The women's health therapeutics market faces significant challenges in the diagnosis and treatment of various diseases, particularly those affecting women's reproductive health. For instance, fallopian tube cancer, which shares symptoms with other gynecologic conditions, can go undetected until advanced stages due to its complex diagnosis. While pelvic exams, ultrasounds, CT scans, MRIs, biopsies, and blood protein tests like CA125 are used for diagnosis, the delay in detection remains a concern. Moreover, adherence to treatment regimens, especially for chronic conditions like osteoporosis, is another challenge. Over-the-counter medications, such as calcium and vitamin D supplements, play a crucial role in osteoporosis prevention.
- However, ensuring patients maintain consistent use is essential for optimal results. Cardiovascular health is another area of concern for women, with stress management and lifestyle modifications being critical factors. Natural remedies like black cohosh and red clover are popular alternatives for managing menopausal symptoms and improving cardiovascular health. Drug development in this field is ongoing, with a focus on creating more effective and patient-friendly treatments. Sexual dysfunction is another common issue for women, with various factors contributing to its prevalence. Effective treatments and therapies, including pharmaceutical interventions and lifestyle modifications, are essential for addressing this concern.
- Ensuring proper treatment adherence and patient education are vital to achieving successful outcomes.
Exclusive Customer Landscape
The women health therapeutics market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the women health therapeutics market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, women health therapeutics market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - This company specializes in women's health therapeutics, including ARACHITOL-O, a unique formulation of calcium citrate malate and vitamin D3. This combination supports bone density and overall well-being for women. The calcium citrate malate aids in calcium absorption, while vitamin D3 promotes calcium utilization in the body. This scientifically-backed approach enhances women's health and wellness.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- AbbVie Inc.
- Amgen Inc.
- Bayer AG
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GLS Pharma Pvt. Ltd.
- ICON plc
- Merck KGaA
- Mithra Pharmaceuticals SA
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- Radius Health Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Tsumura and Co.
- Vivesto AB
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Women Health Therapeutics Market
- In January 2024, Pfizer Inc. Announced the launch of its new women's health product, Lupron Infused Rod for the treatment of uterine fibroids (Source: Pfizer Press Release). This long-acting, subcutaneously administered treatment offers patients an alternative to oral medications and repeated office visits.
- In March 2024, Merck KGaA and F. Hoffmann-La Roche Ltd. Entered into a strategic collaboration to develop and commercialize biosimilar oncology therapies, including those for women's cancers (Source: Merck KGaA Press Release). This partnership combines Merck KGaA's expertise in oncology and Roche's experience in biosimilars, aiming to expand their portfolios and address unmet medical needs.
- In May 2024, Myovant Sciences Inc. Raised USD150 million in a Series C financing round, led by OrbiMed and RA Capital Management (Source: Myovant Sciences Press Release). The funds will support the development and commercialization of their lead product, relugolix, for the treatment of uterine fibroids and endometriosis.
- In April 2025, the European Commission approved AbbVie's AndroGel for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women (Source: AbbVie Press Release). This approval marks the first-ever marketing authorization for testosterone therapy for this indication in Europe, opening up new opportunities for the company in the women's health market.
Research Analyst Overview
- The women's health therapeutics market encompasses a range of interventions aimed at managing hormonal imbalances, mental health concerns, and chronic diseases. Hormone levels play a crucial role in women's health, and hormone panels are essential tools for diagnosis and treatment. Complementary therapies, such as self-care practices and alternative medicine, are increasingly popular for managing symptoms and improving emotional wellbeing. Patient support programs and community support groups offer vital resources for those navigating the complexities of disease prevention and chronic disease management. Monitoring devices, including bone density testing and symptom tracking, enable women to monitor their health and take proactive steps towards risk assessment and health promotion.
- Lifestyle changes, such as dietary recommendations and physical therapy, are key components of preventative care. Health education and public health initiatives are essential for raising awareness about risk factors, early detection, and effective treatment strategies. Genetic testing and risk assessment tools help identify individual risks and inform personalized supplementation strategies and medical interventions. Non-hormonal therapies and pain management techniques are important alternatives for women seeking hormone-free options. Pelvic exams and mental health services are integral components of women's healthcare, ensuring comprehensive care for the whole person. Chronic disease management, including disease prevention and family history assessment, is a significant focus in the women's health therapeutics market.
- Wellness programs and health promotion initiatives offer holistic approaches to maintaining optimal health and managing risk factors. Overall, the market is dynamic and evolving, with a growing emphasis on personalized care and patient-centered approaches.
Dive into Technavio’s robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Women Health Therapeutics Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
180 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
|
Market growth 2024-2028 |
USD 37.2 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
5.6 |
|
Key countries |
US, Germany, UK, France, China, Canada, Japan, Mexico, South Korea, and Brazil |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Women Health Therapeutics Market Research and Growth Report?
- CAGR of the Women Health Therapeutics industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the women health therapeutics market growth of industry companies
We can help! Our analysts can customize this women health therapeutics market research report to meet your requirements.